341 related articles for article (PubMed ID: 7680185)
1. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
[TBL] [Abstract][Full Text] [Related]
2. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
Horton MA; Taylor ML; Arnett TR; Helfrich MH
Exp Cell Res; 1991 Aug; 195(2):368-75. PubMed ID: 1712731
[TBL] [Abstract][Full Text] [Related]
3. Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts.
Shankar G; Davison I; Helfrich MH; Mason WT; Horton MA
J Cell Sci; 1993 May; 105 ( Pt 1)():61-8. PubMed ID: 7689577
[TBL] [Abstract][Full Text] [Related]
4. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Mercer B; Markland F; Minkin C
J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity studies of the s-echistatin inhibition of bone resorption.
Sato M; Garsky V; Majeska RJ; Einhorn TA; Murray J; Tashjian AH; Gould RJ
J Bone Miner Res; 1994 Sep; 9(9):1441-9. PubMed ID: 7817829
[TBL] [Abstract][Full Text] [Related]
6. Echistatin is a potent inhibitor of bone resorption in culture.
Sato M; Sardana MK; Grasser WA; Garsky VM; Murray JM; Gould RJ
J Cell Biol; 1990 Oct; 111(4):1713-23. PubMed ID: 2211834
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions.
Shankar G; Gadek TR; Burdick DJ; Davison I; Mason WT; Horton MA
Exp Cell Res; 1995 Aug; 219(2):364-71. PubMed ID: 7543851
[TBL] [Abstract][Full Text] [Related]
8. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
van der Pluijm G; Mouthaan H; Baas C; de Groot H; Papapoulos S; Löwik C
J Bone Miner Res; 1994 Jul; 9(7):1021-8. PubMed ID: 7942148
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
[TBL] [Abstract][Full Text] [Related]
10. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K
Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
[TBL] [Abstract][Full Text] [Related]
12. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides.
Chang MC; Wang BR; Huang TF
Thromb Haemost; 1995 Aug; 74(2):764-9. PubMed ID: 8585019
[TBL] [Abstract][Full Text] [Related]
13. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
Foster MR; Hornby EJ; Brown S; Kitchin J; Hann M; Ward P
Thromb Res; 1993 Nov; 72(3):231-45. PubMed ID: 8303662
[TBL] [Abstract][Full Text] [Related]
14. Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin.
Helfrich MH; Nesbitt SA; Dorey EL; Horton MA
J Bone Miner Res; 1992 Mar; 7(3):335-43. PubMed ID: 1585836
[TBL] [Abstract][Full Text] [Related]
15. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M
J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
[TBL] [Abstract][Full Text] [Related]
16. Effects of kistrin on bone resorption in vitro and serum calcium in vivo.
King KL; D'Anza JJ; Bodary S; Pitti R; Siegel M; Lazarus RA; Dennis MS; Hammonds RG; Kukreja SC
J Bone Miner Res; 1994 Mar; 9(3):381-7. PubMed ID: 8191932
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of synthetic peptide analogs of adhesive proteins in regard to the interaction of human endothelial cells with extracellular matrix.
Chen CS; Hawiger J
Blood; 1991 May; 77(10):2200-6. PubMed ID: 1709375
[TBL] [Abstract][Full Text] [Related]
18. Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.
Carron CP; Meyer DM; Engleman VW; Rico JG; Ruminski PG; Ornberg RL; Westlin WF; Nickols GA
J Endocrinol; 2000 Jun; 165(3):587-98. PubMed ID: 10828842
[TBL] [Abstract][Full Text] [Related]
19. Soluble alpha v beta 3-integrin ligands raise [Ca2+]i in rat osteoclasts and mouse-derived osteoclast-like cells.
Zimolo Z; Wesolowski G; Tanaka H; Hyman JL; Hoyer JR; Rodan GA
Am J Physiol; 1994 Feb; 266(2 Pt 1):C376-81. PubMed ID: 8141251
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix stimulation of guinea pig megakaryocyte proplatelet formation in vitro is mediated through the vitronectin receptor.
Leven RM; Tablin F
Exp Hematol; 1992 Dec; 20(11):1316-22. PubMed ID: 1283596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
